Barry Zingman is an Infectious Disease physician. OpenAlex indexes 85 publications with 10,749 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JanssenProgram year202527 paymentsResearch$299,185
- PfizerProgram year202517 paymentsResearch$59,104
- ViiV Healthcare CompanyProgram year20255 payments$9,037
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
41.8%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor13%Descovy45%Triumeq35%Zidovudine20%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor11.9%Tivicay100%Part D<11 patients+ 4 more classes in this area
Cardiovascular
32.5%Statin9.1%Atorvastatin Calcium100%Part D≥11 patientsThiazide diuretic7.1%Hydrochlorothiazide100%Part D<11 patients+ 3 more classes in this area
Nervous system
11.5%Gabapentinoids4.8%Gabapentin100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug4.3%Ibuprofen100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2016–2017 per NIH RePORTER. The latest:
- Intervention to increase access to PEP to prevent HIV infection among Black MSM
City College of New York
FY2017$210,800R21AI122996 - Intervention to increase access to PEP to prevent HIV infection among Black MSM
City College of New York
FY2016$255,459R21AI122996
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”